Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, November 13, 2015 4:20:27 PM
bearish 3.68
## source: finance.yahoo.com
Fri, 13 Nov 2015 14:58:35 GMT ~ Edited Transcript of HSGX earnings conference call or presentation 12-Nov-15 1:30pm GMT
read full: http://finance.yahoo.com/news/edited-transcript-hsgx-earnings-conference-145835479.html
*********************************************************
Thu, 12 Nov 2015 13:30:00 GMT ~ Histogenics Corp Earnings Call scheduled for 8:30 am ET today
read full: http://biz.yahoo.com/cc/2/148062.html
*********************************************************
Thu, 12 Nov 2015 12:41:33 GMT ~ Histogenics reports 3Q loss
read full: http://sg.finance.yahoo.com/news/histogenics-reports-3q-loss-124133069.html
*********************************************************
Thu, 12 Nov 2015 12:41:33 GMT ~ Histogenics reports 3Q loss
read full: http://finance.yahoo.com/news/histogenics-reports-3q-loss-124133802.html
*********************************************************
Thu, 12 Nov 2015 12:07:04 GMT ~ Q3 2015 Histogenics Corp Earnings Release - Before Market Open
read full: http://biz.yahoo.com/research/earncal/20151112.html?t=hsgx
*********************************************************
$HSGX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$HSGX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/HSGX/company-info
Ticker: $HSGX
OTC Market Place: Not Available
CIK code: not found
Company name: Histogenics Corporation
Incorporated In:
$HSGX share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$HSGX extra dd links
Company name: Histogenics Corporation
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=HSGX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=HSGX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=HSGX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/HSGX/news - http://finance.yahoo.com/q/h?s=HSGX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/HSGX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/HSGX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=HSGX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/HSGX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Histogenics+Corporation&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Histogenics+Corporation
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Histogenics+Corporation&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/HSGX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/HSGX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/HSGX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=HSGX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=HSGX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/HSGX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=HSGX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=HSGX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=HSGX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=HSGX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=HSGX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/HSGX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=HSGX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/HSGX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=HSGX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/HSGX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/HSGX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/HSGX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/HSGX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/HSGX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=HSGX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=HSGX
$HSGX DD Notes ~ http://www.ddnotesmaker.com/HSGX
Recent OCGN News
- Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to Speak During U.S.-India Initiative on Critical and Emerging Technology Workshop • GlobeNewswire Inc. • 09/09/2024 10:30:12 AM
- Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit • GlobeNewswire Inc. • 09/05/2024 11:00:07 AM
- Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 11:30:42 AM
- Ocugen Announces Completion of Dosing in Subjects with Stargardt Disease in High Dose Cohort of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy • GlobeNewswire Inc. • 08/28/2024 10:30:32 AM
- Ocugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Trial for OCU400 – Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication • GlobeNewswire Inc. • 08/26/2024 11:02:41 AM
- Ocugen, Inc. Investor Alert (NASDAQ: OCGN): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors Following Earnings Restatement and Possible Insider Trading • PR Newswire (US) • 08/20/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 08:16:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:00:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 05:03:56 PM
- Ocugen Provides Business Update with Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 10:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 10:06:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 11:18:41 AM
- Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa • GlobeNewswire Inc. • 08/05/2024 10:30:33 AM
- Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock • GlobeNewswire Inc. • 08/02/2024 07:22:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/01/2024 01:18:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 01:16:00 PM
- Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock • GlobeNewswire Inc. • 08/01/2024 01:15:46 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/31/2024 08:16:21 PM
- Ocugen, Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 07/31/2024 08:15:04 PM
- Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/29/2024 11:02:15 AM
- Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Novel Modifier Gene Therapy • GlobeNewswire Inc. • 07/25/2024 10:30:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:31:01 PM
- Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease • GlobeNewswire Inc. • 06/21/2024 11:00:00 AM
- Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication • GlobeNewswire Inc. • 06/20/2024 10:30:31 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/18/2024 08:29:04 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM